SAN DIEGO, March 24, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and well-being of women, will host a conference call and live webcast at 4:30 ...
With increasing demand for needed treatments designed for women, Daré is taking action to make its proprietary Sildenafil Cream formulation available via prescription this year Enables women to access ...
Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2024 Earnings Call Transcript March 31, 2025 Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.61, expectations were $-0.66. Operator: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results